# EDGAR Filing Document

**Accession Number:** 0001643303
**File Stem:** 0001193125-26-211930
**Filing Date:** 2026-5
**Character Count:** 114640
**Document Hash:** 6138de57fb9f402de2de65ecfffc028d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-211930.hdr.sgml**: 20260507

**ACCESSION NUMBER**: 0001193125-26-211930

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 83

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260507

**DATE AS OF CHANGE**: 20260507

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nano Dimension Ltd.
- **CENTRAL INDEX KEY:** 0001643303
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRINTED CIRCUIT BOARDS [3672]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 520029109
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37600
- **FILM NUMBER:** 26953424

**BUSINESS ADDRESS:**
- **STREET 1:** 60 TOWER ROAD,
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451
- **BUSINESS PHONE:** 972 54 6244465

**MAIL ADDRESS:**
- **STREET 1:** 60 TOWER ROAD,
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451

?xml version='1.0' encoding='ASCII'? 10-Q

**pro**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

------

**FORM** 10-Q

------

**(Mark One)** 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**For the quarterly period ended** **March 31,** 2026

**OR** 

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**For the transition period from to** 

**Commission File No.:** 001-37600

------

NANO DIMENSION LTD.

**(Exact name of registrant as specified in its charter)**

------

---

| | |
|:---|:---|
| **State of** Israel | 52-0029109 |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer**<br>**Identification No.)** |
| 60 Tower Road <br>Waltham**,** MA | 02451 |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (**866**)** 496-1805

------

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| Title of each class | Name of each exchange on which registered |
| American Depositary Shares **each representing one Ordinary Share par value NIS 5.00 per share (1) Ordinary Shares, par value NIS 5.00 per share (2)**<br> NNDM | The Nasdaq Stock Market LLC |
| Rights to Purchase American Depositary Shares**, each American Depositary Share representing one Ordinary Share, par value NIS 5.00 per share**<br> NNDM | The Nasdaq Stock Market LLC |

---

(1)Evidenced by American Depositary Receipts.

(2)Not for trading, but only in connection with the listing of the American Depositary Shares.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of Registrant's Ordinary Shares outstanding as of May 5, 2026 was 209,208,591.

------

**CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS**

Certain information included or incorporated by reference in this Quarterly Report on Form 10-Q may be deemed to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Forward-looking statements are often characterized by the use of forward-looking terminology such as "may," "will," "expect," "anticipate," "estimate," "continue," "believe," "should," "intend," "project" or other similar words, but are not the only way these statements are identified.

These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition, expected capital needs and expenses, statements relating to the research, development, completion and use of our products, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.

Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.

Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the outcome of the independent process now being conducted to evaluate strategic alternatives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the integration of the operations of Markforged into our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the transformation of our business resulting from the change in our management;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•changes in our strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the impact of competition and new technologies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•shareholder activism;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the overall global economic environment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•geopolitical tensions and political events, including the ongoing war between Ukraine and Russia and the conflict in the Middle East, including the ongoing war between Iran and Israel;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•projected capital expenditures and liquidity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•litigation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•those factors referred to in "PART I. Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations," as well as in this Quarterly Report on Form 10-Q generally.

Readers are urged to carefully review and consider the various disclosures made throughout this Quarterly Report on Form 10-Q which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

You should not put undue reliance on any forward-looking statements. Any forward-looking statements in this Quarterly Report on Form 10-Q are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Further information on potential risk factors that could affect our financial results are included in the filings made by us from time to time with the SEC including under the sections entitled "Risk Factors" in our Annual Report on Form 10-K filed with the SEC on March 31, 2026.

i

------

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| PART I. | FINANCIAL INFORMATION |  |
| Item 1. | &nbsp;&nbsp;&nbsp;&nbsp;Condensed Consolidated Financial Statements  |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 (Unaudited)</u>](#consolidated_balance_sheets) | 1 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2026 and 2025 (Unaudited)</u>](#consolidated_statements_of_comprehensive) | 2 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2026 and 2025 (Unaudited)</u>](#consolidated_statements_ofchanges_equity) | 3 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[<u>Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (Unaudited)</u>](#consolidated_statements_of_cash_flows) | 4 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;[<u>Notes to Condensed Consolidated Financial Statements (Unaudited)</u>](#notes_to_consolidated_financial) | 5 |
| Item 2. | [<u>Management's Discussion and Analysis of Financial Condition and Results of Operations.</u>](#item_2_mda) | 19 |
| Item 3. | [<u>Quantitative and Qualitative Disclosures About Market Risk.</u>](#item_3_quantitative_and_qualitative) | 27 |
| Item 4. | [<u>Controls and Procedures.</u>](#item_4_controls_and_procedures) | 27 |
| PART II | OTHER INFORMATION |  |
| Item 1. | [<u>Legal Proceedings</u>](#item_1_legal_proceedings) | 28 |
| Item 1A. | [<u>Risk Factors</u>](#item_1a_risk_factors) | 29 |
| Item 2. | &nbsp;&nbsp;&nbsp;&nbsp;[<u>Unregistered Sales of Equity Securities and Use of Proceeds</u>](#item_2_unregistered_sales_of_equity_sec) | 29 |
| Item 3. | &nbsp;&nbsp;&nbsp;&nbsp;[<u>Defaults Upon Senior Securities</u>](#item_3_defaults_upon_senior_securities) | 29 |
| Item 4. | [<u>Mine Safety Disclosures</u>](#item_4_mine_safety_disclosures) | 29 |
| Item 5. | [<u>Other Information</u>](#item_5_other_information) | 29 |
| Item 6. | [<u>Exhibits</u>](#item_6_exhibits) | 30 |
| [<u>Signatures</u>](#signatures) |  | 31 |

---

ii

------

**NANO DIMENSION LTD.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(In thousands, except share and per share data) (Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **March 31,** | **December 31,** |
|  | **2026** | **2025** |
| **Assets** |  |  |
| Current assets: |  |  |
| Cash and cash equivalents | $355278 | $204672 |
| Bank deposits | 8781 | 168997 |
| Marketable equity securities | 75719 | 84154 |
| Restricted bank deposits | 594 | 123 |
| Trade receivables, net of allowance for doubtful<br> accounts ($939 and $861, respectively) | 22700 | 26047 |
| Inventory | 31703 | 32878 |
| Other current assets | 10622 | 8938 |
| Total current assets | 505397 | 525809 |
| Restricted bank deposits | 1254 | 1610 |
| Property, plant and equipment, net | 23621 | 24840 |
| Operating lease right-of-use assets | 22487 | 23789 |
| Deferred tax assets | 424 | 424 |
| Goodwill |  | 40388 |
| Intangible assets, net | 18313 | 19434 |
| Other assets | 1711 | 1930 |
| Total assets | $573207 | $638224 |
| **Liabilities and Equity** |  |  |
| Current liabilities: |  |  |
| Trade payables | $12974 | $11999 |
| Accrued liabilities | 21083 | 19514 |
| Deferred revenue | 13250 | 11873 |
| Current portion of lease liability | 8604 | 8923 |
| Current portion of bank loan | 156 | 158 |
| Total current liabilities | 56067 | 52467 |
| Employee benefits | 3666 | 3697 |
| Operating lease right-of-use liabilities | 21563 | 23323 |
| Bank loan | 117 | 158 |
| Long-term settlement payable | 3124 | 2974 |
| Long-term deferred revenue | 3226 | 3617 |
| Total liabilities | 87763 | 86236 |
| Commitments and contingencies (Note 11) |  |  |
| Equity: |  |  |
| Share capital of NIS 5 par value each; 500,000,000 ordinary shares<br> authorized; 207,986,287 and 206,811,875 shares outstanding as of March 31, 2026 <br> and December 31, 2025, respectively, and 280,480,934 and 279,306,522 shares<br> issued as of March 31, 2026 and December 31, 2025, respectively. | 418969 | 417084 |
| Additional paid-in capital | 1298363 | 1297323 |
| Treasury stock | (192507) | (192507) |
| Accumulated other comprehensive income | 1241 | 1048 |
| Accumulated loss | (1040622) | (970960) |
| Total equity | 485444 | 551988 |
| Total liabilities and equity | $573207 | $638224 |
| See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. |

---

------

**NANO DIMENSION LTD.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS**

**(In thousands, except share data) (Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Revenue: |  |  |
| Product | $22931 | $11679 |
| Service | 6794 | 2722 |
| Total revenue | 29725 | 14401 |
| Cost of revenue: |  |  |
| Product | 14222 | 7081 |
| Service | 3376 | 1479 |
| Total cost of revenue | 17598 | 8560 |
| Gross profit | 12127 | 5841 |
| Operating expenses: |  |  |
| Research and development | 8204 | 5944 |
| Sales and marketing | 9692 | 5644 |
| General and administrative | 15209 | 5667 |
| Restructuring | 3127 | 1180 |
| Desktop Metal litigation |  | 28069 |
| Impairment losses | 40388 | 1229 |
| Operating loss | (64493) | (41892) |
| (Loss) gain on investment in marketable equity securities | (8435) | 8726 |
| Finance income | 3512 | 9320 |
| Finance expense | (246) | (1679) |
| Loss before income taxes | (69662) | (25525) |
| Income tax expense |  | (23) |
| Net loss | (69662) | (25548) |
| Less: Net loss attributable to non-controlling interests |  | (236) |
| Net loss attributable to common shareholders | $(69662) | $(25312) |
| Net loss attributable to common shareholders: |  |  |
| Basic and diluted | $(0.34) | $(0.12) |
| Weighted average common shares outstanding, basic and diluted | 207504 | 216462 |
| Net loss | $(69662) | $(25548) |
| Other comprehensive income: |  |  |
| Foreign currency translation adjustment | 193 | 593 |
| Comprehensive loss | (69469) | (24955) |
| Less: Comprehensive loss attributable to non-controlling interests |  | (224) |
| Comprehensive loss attributable to common shareholders | $(69469) | $(24731) |
| See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. |

---

------

**NANO DIMENSION LTD.**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

**(In thousands) (Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Share<br>Capital** | **Additional<br>Paid-In<br>Capital** | **Treasury<br>Stock** | **Accumulated<br>Other<br>Comprehensive<br>Income (Loss)** | **Accumulated<br>Deficit** | **Total** | **Non-<br>Controlling<br>Interests** | **Total<br>Equity** |
| **December 31, 2024** | $**409145** | $**1297348** | $**(167651)** | $**(1137)** | $**(677665)** | $**860040** | $**715** | $**860755** |
| Net loss |  |  |  |  | (25312) | (25312) | (236) | (25548) |
| Comprehensive income for the period |  |  |  | 581 |  | 581 | 12 | 593 |
| Exercise of warrants, options and vesting of RSUs | 1828 | (1828) |  |  |  |  |  |  |
| Share-based compensation expense |  | (786) |  |  |  | (786) |  | (786) |
| **March 31, 2025** | **410973** | **1294734** | **(167651)** | **(556)** | **(702977)** | **834523** | **491** | **835014** |
| **December 31, 2025** | **417084** | **1297323** | **(192507)** | **1048** | **(970960)** | **551988** | **—** | **551988** |
| Net loss |  |  |  |  | (69662) | (69662) |  | (69662) |
| Comprehensive income for the period |  |  |  | 193 |  | 193 |  | 193 |
| Exercise of warrants, options and vesting of RSUs | 1885 | (1885) |  |  |  |  |  |  |
| Share-based compensation expense |  | 2925 |  |  |  | 2925 |  | 2925 |
| **March 31, 2026** | $**418969** | $**1298363** | $**(192507)** | $**1241** | $**(1040622)** | $**485444** | $— | $**485444** |
| See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. |

---

------

**NANO DIMENSION LTD.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(In thousands) (Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** |
|  | **2026** | **2025** |
| **Cash flow from operating activities** |  |  |
| Net loss | $(69662) | $(25548) |
| Adjustments: |  |  |
| Depreciation, amortization and non-cash lease interest | 3701 | 574 |
| Impairment losses | 40388 | 1229 |
| Changes in fair value of equity securities | 8435 | (8726) |
| Share-based compensation expense | 2925 | (786) |
| Changes in assets and liabilities: |  |  |
| (Increase) decrease in inventory | 425 | 340 |
| (Increase) in other current assets | (1500) | (371) |
| Decrease (increase) in trade receivables | 3258 | (2881) |
| Increase (decrease)in other payables | 1609 | (4026) |
| (Decrease) increase in employee benefits | (20) | 38 |
| Increase in trade payables | 1019 | 26362 |
| Other | 2343 | 6316 |
| Net cash used in operating activities | (7079) | (7479) |
| **Cash flow relating to investing activities** |  |  |
| Change in bank deposits | 157651 | 177395 |
| Purchase of property plant and equipment | (167) | (295) |
| Net cash from investing activities | 157484 | 177100 |
| **Cash flow relating to financing activities** |  |  |
| Repayment long-term bank debt | (41) | (35) |
| Net cash used in financing activities | (41) | (35) |
| Increase in cash, cash equivalents and restricted cash | 150364 | 169586 |
| Effect of exchange rate fluctuations on cash | 357 | 204 |
| Cash, cash equivalents and restricted cash at beginning of the period | 206405 | 318474 |
| **Cash, cash equivalents and restricted cash at end of the period** | $357126 | $488264 |
| **Supplemental disclosures of cash flow information** |  |  |
| Cash and cash equivalents | $355278 | 487438 |
| Restricted cash in restricted deposits, current | 594 | 60 |
| Restricted cash in restricted deposits, non-current | 1254 | 766 |
| Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows | $357126 | $488264 |
| **Non-cash operating and investing activity** |  |  |
| Lease liabilities arising from obtaining right-of-use assets |  | 119 |
| **Supplemental disclosure of cash flow information** |  |  |
| Income taxes paid during the year |  | 60 |
| See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. | See Notes to Condensed Consolidated Financial Statements. |

---

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data) (Unaudited)**

# <u>Note 1 – Description of Business</u> 
**Reporting Entity**

Nano Dimension Ltd. (the "Company") is an Israeli resident company incorporated in Israel. Until April 11, 2025, the address of the Company's principal executive office was 2 Ilan Ramon St., Ness Ziona 7403635, Israel. Effective from that date, the Company's principal executive office is located at 60 Tower Road, Waltham, Massachusetts, 02451, United States. Unless otherwise indicated, all references to the "Company," refer to Nano Dimension Ltd. and its subsidiaries, Global Inkjet Systems Ltd. ("GIS"), a United Kingdom corporation, Nano Dimension Technologies Ltd. ("Nano Tech"), an Israeli corporation, Essemtec AG ("Essemtec") and Nano Dimension Swiss GmbH ("Nano Swiss"), Swiss corporations, Formatec Holding B.V. ("Formatec Holding") (which is in the process of liquidation), Admatec Europe B.V. ("Admatec") (which is in the process of liquidation) and Formatec Technical Ceramics B.V. ("Formatec") (which is in the process of liquidation), Dutch corporations, Nano Dimension USA Inc. ("Nano USA"), a Delaware corporation, Essemtec USA, LLC, a Delaware limited liability company, Nano Dimension GmbH ("Nano Germany") and Essemtec Deutschland GmbH, German corporations, Nano Dimension Australia Pty Ltd. ("Nano Australia"), an Australian corporation, Nano Dimension (HK) Limited, a Hong Kong corporation, Essemtec France SAS, a French corporation, Nano Dimension NY Ltd., a New York corporation, Nano Dimension Trading (Shenzhen) Ltd., a Chinese corporation, and Markforged Holding Corporation ("Markforged") and Desktop Metal, Inc. ("Desktop Metal"), Delaware corporations. The Company engages in industrial manufacturing solutions of multi-disciplinary technology - combining hardware, software, and materials science. These solutions are used for design-to-manufacturing of electronics and mechanical parts by advanced industrial customers in aerospace, defense, automotive, electronics, medical, research and academia, as well as government organizations. Since March 2016, the Company's American Depositary Shares ("ADSs") have been trading on the Nasdaq Capital Market ("Nasdaq").

**Material events in the reporting period**

***Conflicts in the Middle East***

On February 28, 2026, the U.S. and Israel initiated air strikes against Iranian military targets and leadership. Since then, retaliation by Iran against U.S. and Israeli interests in the Middle East has been widespread. As of the date of the filing of this Quarterly Report on Form 10-Q, military activity and hostilities continue to escalate in the Middle East, and the situation throughout the region remains volatile, with the potential for continued escalation into a broader and more sustained regional conflict.

# <u>Note 2 - Summary of Significant Accounting Policies</u> 
**Basis of Presentation** 

The accompanying unaudited condensed consolidated financial statements of the Company are prepared in conformity with accounting principles generally accepted in the United States of America ("US GAAP") and pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"), the instructions to Form 10-Q and the provisions of Regulation S-X pertaining to interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC. The unaudited condensed consolidated financial statements include the Company's accounts and those of its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. In the opinion of the Company's management, the financial information for the interim periods presented reflects all adjustments, which are of a normal and recurring nature, necessary for a fair statement of the Company's financial position, results of operations, and cash flows. The results reported in these unaudited condensed consolidated financial statements are not necessarily indicative of results that may be expected for the entire year. These financial statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 31, 2026. Certain reclassifications have been made to prior year presentation to conform to current year presentation.

**Fair Value Measurements**

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

The Company is required to provide information according to the fair value hierarchy based on the observability of the inputs used in the valuation techniques. The fair value hierarchy ranks the quality and reliability of the information used to determine fair values. Financial assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs which are supported by little or no market activity.

Financial instruments consist of cash equivalents, bank deposits, marketable securities, trade receivables, other receivables, trade payables, accrued liabilities, other current liabilities and derivative financial instruments. Derivative financial instruments are stated at fair value on a recurring basis. Cash equivalents, bank deposits, trade receivables, other receivables, trade payables, accrued liabilities and other current liabilities, are stated at their carrying value, which approximates their fair value due to the short time to the expected receipt or payment date.

The Company measures investment in marketable equity securities at fair value on the condensed consolidated statements of operations and comprehensive loss.

The Company's financial assets that are measured at fair value on a recurring basis by level within the fair value hierarchy are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Current assets: |  |  |  |  |
| Money market funds | $6925 | $— | $— | $6925 |
| Bank deposits | 334415 |  |  | 334415 |
| Marketable equity securities | 75719 |  |  | 75719 |
| Total assets measured at fair value | $417059 | $— | $— | $417059 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** |
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Current assets: |  |  |  |  |
| Money market funds | $8403 | $— | $— | $8403 |
| Bank deposits | 339851 |  |  | 339851 |
| Marketable equity securities | 84154 |  |  | 84154 |
| Total assets measured at fair value | $432408 | $— | $— | $432408 |

---

There were no transfers between fair value levels during 2026 and 2025.

**Goodwill**

Goodwill represents the future economic benefits arising from other assets acquired in a business combination that is not individually identified and separately recorded. The excess of the purchase price over the estimated fair value of net assets of businesses acquired in a business combination is recognized as goodwill. Goodwill is not amortized but is tested for impairment annually at the start of the fourth quarter, or as circumstances indicate that the carrying value of the asset may not be recoverable through future operations.

The Company reviews goodwill for impairment utilizing either a qualitative assessment or a quantitative goodwill impairment test. If we choose to perform a qualitative assessment and we determine that the fair value of the reporting unit more likely than not exceeds the carrying value, no further evaluation is necessary. When we perform the quantitative goodwill impairment test, we determine fair value using accepted valuation techniques, which can include the market and discounted cash flow methods. The fair value of the reporting unit is compared to the carrying value, which includes goodwill. If the fair value of the reporting unit

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

exceeds its carrying value, we do not consider the goodwill impaired. If the carrying value is higher than the fair value, we recognize the difference as an impairment loss, limited to the total amount of goodwill.

A quantitative goodwill impairment testing process requires valuation of the reporting unit. In the market approach, we can reference the Company's market capitalization as a value indication given the Company's single operating segment and reporting unit. In the income approach, which is based on a discounted forecasted cash flow including a terminal value, we compute the terminal value using the constant growth method, which values the forecasted cash flows in perpetuity. The assumptions about future cash flows and growth rates are based on the reporting unit's long-term forecast and is subject to review and approval by senior management. A reporting unit's discount rate is a significant assumption and is a risk-adjusted weighted average cost of capital, which we believe approximates the rate from a market participant's perspective. The estimated fair value could be impacted by changes in market conditions and various other assumptions, however we consider the discount rate assumption to be the key assumption. We categorize the fair value determination as Level 3 in the fair value hierarchy due to its use of internal projections and unobservable measurement inputs.

**Revenue Recognition**

The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") Topic 606, *Revenue from Contracts with Customers* ("ASC Topic 606"). Under ASC Topic 606, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of the revenue recognition accounting standard, the Company performs the following five steps:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•identifies the contract with a customer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•identifies the performance obligations in the contract;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•determines the transaction price;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•allocates the transaction price to the performance obligations in the contract; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•recognizes revenue when (or as) the entity satisfies a performance obligation.

On the contract's inception date, the Company assesses the goods or services promised in the contract with the customer and identifies as a performance obligation any promise to transfer to the customer goods or services (or a bundle of goods or services) that are distinct.

The Company identifies goods or services promised to the customer as being distinct when the customer can benefit from the goods or services on their own or in conjunction with other readily available resources and the Company's promise to transfer the goods or services to the customer is separately identifiable from other promises in the contract. The Company's identified performance obligations include printer, ink, maintenance (which is generally provided for a period of up to one year), training and installation. In some cases, the Company recognizes a warranty as a distinct service to the customer and is, therefore, a distinct performance obligation.

Revenue is allocated among performance obligations in a manner that reflects the consideration that the Company expects to be entitled to for the promised goods based on the standalone selling prices ("SSP") of the goods or services of each performance obligation. If a SSP is not directly observable, the Company allocates the transaction price to the identified performance obligations based on the residual approach, while allocating the estimated SSP for performance obligations relating to maintenance, training and installation services, and the residual is allocated to printers.

Revenue allocated to printers, installation and training, and ink and other consumables are recognized when the control is passed in accordance with the contract terms at a point in time. Maintenance revenue is recognized ratably, on a straight-line basis, over the period of the services. Revenue from training and installation is recognized at the time of performance. Revenue from development services is recognized only when the relevant contractual milestone is achieved, and recognition is contingent upon such achievement.

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

Product revenue is generally recognized when the customer obtains control of the Company's product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract. Service revenue is generally recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation.

**Recently Issued Accounting Pronouncements Not Yet Adopted** 

In November 2024, the FASB issued ASU No. 2024-03, "Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses." This ASU requires an entity to disclose the amounts of purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each relevant expense caption. It also requires an entity to include certain amounts that are already required to be disclosed under current GAAP in the same disclosure. Additionally, it requires an entity to disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, and to disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. The amendments in the ASU are effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on its disclosures in the condensed consolidated financial statements.

In December 2025, the FASB issued ASU-2025-10, "Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities" which establishes authoritative guidance on the accounting for government grants received by business entities. The guidance is effective for annual periods beginning after December 15, 2028, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the effect this standard will have on its condensed consolidated financial statements and related disclosures.

In December 2025, the FASB issued ASU 2025-11, "Interim Reporting (Topic 270): Narrow-Scope Improvements," which is intended to improve the navigability of the guidance in ASC 270 and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP. ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently assessing the impact ASU 2025-11 will have on the Company's interim condensed consolidated financial statements.

# <u>Note 3 - Allowance for doubtful accounts</u> 
The following is a summary of the activity of the Company's allowance for doubtful accounts:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Beginning balance | $861 | $811 |
| Provisions | 74 | 111 |
| Write-offs |  |  |
| Foreign currency adjustment | 4 | 1 |
| Ending balance | $939 | $923 |

---

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

# <u>Note 4 – Other current assets</u> 

# Other current assets consist of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31,** | **December 31,** |
|  | **2026** | **2025** |
| Government authorities | $3094 | $2767 |
| Prepaid expenses | 6119 | 4363 |
| Other | 1409 | 1808 |
| Other current assets | $10622 | $8938 |

---

# <u>Note 5 – Inventory</u> 

# Inventory consists of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31,** | **December 31,** |
|  | **2026** | **2025** |
| Raw materials | $10503 | $10659 |
| Work in progress | 4724 | 3803 |
| Finished goods | 16476 | 18416 |
| Inventory | $31703 | $32878 |

---

# <u>Note 6 – Property, plant and equipment, net</u> 
The composition of property, plant and equipment, net is as follows:

---

| | | |
|:---|:---|:---|
|  | **March 31,** | **December 31,** |
|  | **2026** | **2025** |
| Machinery, equipment and vehicles | 25203 | $24830 |
| Computer hardware and software | 8422 | 8416 |
| Furniture and fixtures | 2533 | 2548 |
| Leasehold improvements | 17246 | 16839 |
| Buildings | 7121 | 7185 |
| Other | 49 | 630 |
| Total | 60574 | 60448 |
| Less: Accumulated depreciation | (36953) | (35608) |
| Property, plant and equipment, net | $23621 | $24840 |

---

# <u>Note 7 – Goodwill and Intangible Assets</u> 
**Goodwill**

The following table represents the change in the carrying value of goodwill for the three months ended March 31, 2026:

---

| | |
|:---|:---|
|  | **Activity** |
| Balance as of December 31, 2025 | $40388 |
| Impairment of Markforged Goodwill | (40388) |
| Balance as of March 31, 2026 | $— |

---

As a result of our ongoing strategic review process, there was an indicator of value for the Markforged FFF product line that was a triggering event for a goodwill impairment review. As a result, the Company conducted a goodwill impairment review and it was determined that the entire Markforged FFF product line goodwill balance was impaired as of March 31, 2026.

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

**Intangible assets, net**

The following table displays intangible assets, net by major class:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Gross** | **Accumulated Amortization** | **Net** | **Gross** | **Accumulated Amortization** | **Net** |
| Technology | $13636 | $(2082) | $11554 | $13636 | $(1519) | $12117 |
| Mutual licensing under <br>settlement agreement | 5320 | (220) | 5100 | 5320 | (156) | 5164 |
| Trademark | 1811 | (1660) | 151 | 1811 | (1207) | 604 |
| Customer relationships | 1660 | (152) | 1508 | 1660 | (111) | 1549 |
| Intangible assets | $22427 | $(4114) | $18313 | $22427 | $(2993) | $19434 |

---

The Company recognized amortization expense of intangible assets as follows:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Cost of revenue | $578 | $80 |
| Operating expenses | 494 |  |
| Total | $1072 | $80 |

---

Expected resulting revenue is the basis for the economic pattern used to determine the amortization schedule of technology and customer relationships. Trademark intangible amortization is based on the term in which the Company anticipates using the asset. Amortization related to technology and mutual licensing under a settlement agreement are recorded to cost of revenue on the condensed consolidated statements of operations and comprehensive loss. Amortization related to trademarks and customer relationships are recorded in sales and marketing expense on the condensed consolidated statements of operations and comprehensive loss.

As of March 31, 2026, estimated amortization expense for intangible assets for each of the next five fiscal years and thereafter is expected to be as follows:

---

| | |
|:---|:---|
| **For the Years Ended December 31,** | **Estimated Amortization Expense** |
| 2026 (remaining nine months) | $2155 |
| 2027 | 2673 |
| 2028 | 2673 |
| 2029 | 2673 |
| 2030 | 2673 |
| Thereafter | 5466 |
| Total intangible assets, net | $18313 |

---

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

# <u>Note 8 – Accrued liabilities</u> 

# Accrued liabilities consist of the following:

---

| | | |
|:---|:---|:---|
|  | **March 31,** | **December 31,** |
|  | **2026** | **2025** |
| Employees and related liabilities | $7654 | $7589 |
| Professional services | 2533 | 2209 |
| Government authorities | 2210 | 2870 |
| Contingencies | 3268 | 2123 |
| Current portion of settlement payable | 2000 | 2000 |
| Other | 3418 | 2723 |
| Accrued liabilities | $21083 | $19514 |

---

# <u>Note 9 – Equity</u> 
Share capital activity was as follows (in thousands of shares of NIS 5 par value per share):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Ordinary shares** | **Ordinary shares** | **Ordinary shares** | **Ordinary shares** |
|  | **2026** | **2026** | **2025** | **2025** |
| Shares outstanding as of January 1 |  | 206,812 |  | 215,777 |
| Exercise of share options and vesting of RSUs during the period |  | 1,174 |  | 1,315 |
| Shares outstanding as of March 31 |  | 207,986 |  | 217,092 |

---

**Rights Plan**

In January 2024, the Company entered into a rights agreement, or the Original Rights Plan. The Original Rights Plan was designed to reduce the likelihood that any entity, person or group would gain control of, or significant influence over the Company. The Original Rights Plan expired on January 25, 2025.

In February 2026, the Company entered into a rights agreement, or the Rights Plan. The Rights Plan was designed to reduce the likelihood that any entity, person or group would gain control of, or significant influence over the Company. The Rights Plan will expire on February 1, 2027.

**Stock Options, RSUs and Warrants**

The Company has in effect the Employee Stock Option Plan (2015) (the "2015 Plan").

The 2015 Plan was adopted by Company's board of directors in February 2015, and expired in February 2026. On December 4, 2025, the shareholders of the Company approved a resolution to extend the 2015 Plan by an additional one-year period ending in February 2027. The Company's employees, directors, officers, consultants, advisors, and suppliers are eligible to participate in this plan.

On March 13, 2019, the Company's board of directors adopted an appendix to the 2015 Plan for U.S. residents. Under this appendix, the 2015 Plan provides for the granting of options to U.S. residents in compliance with the U.S. Internal Revenue Code of 1986, as amended.

Of these outstanding awards, as of March 31, 2026, 290,834 options to purchase ordinary shares were vested and exercisable.

<u>Stock options</u>

The share options vest over a period of four years. The share options will be exercisable, in consideration of an exercise price, until the earlier of (a) the anniversary of the vesting date of such options, or (b) 90 days from the end of employment date.

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

A summary of the Company's stock option activity and related information is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Number<br>of options** | **Weighted<br>average<br>exercise price** | **Weighted<br>average<br>intrinsic value** |
| Outstanding on December 31, 2025 | 298334 | $3.57 | $0.02 |
| Granted |  |  |  |
| Exercised |  |  |  |
| Forfeited and expired |  |  |  |
| Outstanding on March 31, 2026 | 298334 | 3.57 | 0.03 |
| Exercisable as of March 31, 2026 | 290834 | 3.59 | 0.03 |

---

The total intrinsic value of options exercised during the three months ended March 31, 2026 and 2025 were none and $0.1 million, respectively.

The weighted average remaining contractual life of the outstanding options is 2.4 years as of March 31, 2026.

<u>Restricted stock units ("RSU")</u>

A summary of the Company's RSU activity is as follows:

---

| | | |
|:---|:---|:---|
|  |  | **Weighted** |
|  |  | **average** |
|  | **Number of Units** | **grant price** |
| Outstanding on December 31, 2025 | 6222034 | $1.86 |
| Granted | 1081040 | 1.56 |
| Vested | (1174412) | 2.21 |
| Forfeited | (96971) | 1.82 |
| Outstanding on March 31, 2026 | 6031691 | $1.75 |

---

The weighted average fair values at grant date of RSUs granted for the three months ended March 31, 2026 and 2025 were $1.56 and $2.26 per share, respectively.

The total fair value of shares vested during the three months ended March 31, 2026 and 2025 was $3.0 million and $1.3 million, respectively. As of March 31, 2026, there were 927,833 RSUs that were vested but not issued and outstanding due to timing. As such, these shares are excluded from the vested amount in the above table and are included as outstanding RSUs.

As of March 31, 2026, the Company had approximately $7.2 million of unrecognized compensation expense related to non-vested stock options and non-vested RSU's, expected to be recognized over a weighted average period of 1.6 years.

<u>Warrants</u> 

A summary of the Company's warrants activity and related information is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | **Weighted** |
|  |  |  | **average** |
|  |  | **Weighted** | **remaining** |
|  |  | **average** | **contractual** |
|  |  | **exercise** | **life (in** |
|  | **Warrants** | **price** | **years)** |
| Outstanding on December 31, 2025 | 29242103 | $5.96 | 1.60 |
| Granted |  |  |  |
| Exercised |  |  |  |
| Expired |  |  |  |
| Outstanding and exercisable as of March 31, 2026 | 29242103 | $5.96 | 1.60 |

---

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

As of March 31, 2026, the outstanding warrants include 27,742,103 Series B warrants issued to Stern YOI Ltd. Partnership in August 2020 to purchase Ordinary Shares at an exercise price of $6.16 per ADS and expiring in August 2027. Stern YOI Ltd. Partnership is a Nevada limited partnership. Mr. Yoav Stern, former Chief Executive Officer of Nano Dimension Ltd., is a managing member of Stern YOI Ltd. Partnership. In September 2020, the Company issued 1,500,000 warrants to purchase 1,500,000 ADSs to the Company's former director, Mr. Yaron Eitan, in consideration of $150,000. The warrants have an exercise price of $2.25 per ADS and will expire in September 2027.

**<u>Stock-Based Compensation</u>**

Stock-based compensation expense related to stock options and RSUs is included in the condensed consolidated statements of operations and comprehensive loss as follows:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  | **2026** | **2025** |
| Cost of revenue | $158 | $246 |
| Research and development expenses | 478 | 69 |
| Sales and marketing expenses | 200 | 323 |
| General and administrative expenses | 2089 | (1424) |
|  | $2925 | $(786) |

---

# <u>Note 10 – Revenue</u> 
The Company has one operating and reportable segment, which generates revenue via industrial manufacturing solutions of multi-disciplinary technology - combining hardware, software, and materials science.

Revenue per geographical location is as follows:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Americas | $12256 | $4756 |
| APAC | 4695 | 1490 |
| EMEA | 12774 | 8155 |
| Total revenue | $29725 | $14401 |

---

The following table disaggregates the Company's revenue by the timing of transfer of products or services:

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| Services transferred over time | $5093 | $1387 |
| Goods transferred at a point in time | 24632 | 13014 |
| Total revenue | $29725 | $14401 |

---

<u>Contract balances</u>

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company has a right to bill when products are shipped, which is often the point in time revenue is recognized. As a result, the Company will have accounts receivable for billings and also deferred revenue for the portion of billings in advance of service in its hardware maintenance agreements.

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

The Company recognized $4.2 million of revenue during the three months ended March 31, 2026 from deferred revenue as of December 31, 2025. The Company recognized $1.0 million of revenue during the three months ended March 31, 2025 from deferred revenue as of December 31, 2024.

Deferred revenue is expected to be recognized when the Company provides hardware maintenance services or contractual performance obligations for which the customer has already provided payment with $12.3 million to be recognized in the remainder of 2026, $2.8 million in 2027, $1.0 million in 2028, and $0.4 million thereafter. These deferred revenues are included within other long-term liabilities on the condensed consolidated balance sheets.

# <u>Note 11 – Commitments and contingencies</u> 
From time to time, the Company may face legal claims or actions in the normal course of business. At each reporting date, the Company evaluates whether a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that address accounting for contingencies. The Company expenses the costs related to its legal proceedings as incurred.

On September 20, 2024, Markforged entered into a settlement agreement with Continuous Composites related to previous litigation (the "Settlement Agreement") to resolve all claims and counterclaims. Under the terms of the Settlement Agreement, Markforged made an initial upfront payment of $18 million to Continuous Composites on October 10, 2024, and is required to make three additional installment payments thereafter of $1 million, $2 million and $4 million in the fourth quarters of fiscal years 2025, 2026 and 2027, respectively. In consideration of such payments, the Settlement Agreement provides for a dismissal of all claims with prejudice, cross-licenses of the parties' respective patent portfolios, a mutual release of claims for liabilities arising prior to the effective date of the Settlement Agreement and mutual covenants not to sue. The incremental amount due under the Settlement Agreement compared to the original verdict is determined to be representative of the amount attributable to the licensing of the patent rights contemplated under the Settlement Agreement and was recognized as an intangible asset of $5.5 million, after discount using a rate of 12%, to be amortized to cost of revenue over the 23 year life of the patents. Total amortization expense of $0.2 million was recognized from the period of acquisition through the year ended December 31, 2025, and included in cost of revenue. The Company paid $1.0 million during 2025 and the remaining future payments of $6.0 million under the Settlement Agreement as of December 31, 2025 are secured by the Security Agreement. The Company has recorded a settlement payable on the condensed consolidated balance sheet of $5.0 million, of which $2.0 million is a current liability. The settlement payable will accrete $1.0 million over the remaining payment term recognized as interest expense. Interest expense related to settlement payable was $0.1 million for the three months ended March 31, 2026.

On July 8, 2025, Quinn Emanuel Urquhart & Sullivan, LLP ("Quinn") filed a lawsuit against Nano Dimension Ltd. and Ofir Baharav ("Defendants"). Quinn alleges that Defendants tortiously interfered with Quinn's contract with Desktop Metal, and prevented Desktop Metal from paying Quinn approximately $30.0 million. Quinn also asserts that Defendants are liable pursuant to an alleged attorney's lien and engaged in unfair and deceptive practices, in violation of Massachusetts law. The case is pending in the Business Litigation Session of the Suffolk Superior Court in Massachusetts. Defendants moved to dismiss. That motion was fully briefed in February 2026, argued on March 16, 2026, and remains pending.

During the third quarter of 2025, certain former employees or vendors of the Company or its subsidiaries filed lawsuits alleging that the Company is in breach of certain agreements and are entitled to certain compensation and other benefits. While other matters are still ongoing, the Company believes that it is probable that some amount of loss has been incurred and has accrued approximately $2.2 million, including an increase of $1.1 million during the first quarter of 2026 as an estimated probable loss which is included as part of general and administrative operating expenses.

During the fourth quarter of 2025, Markforged processed a $1.4 million payment to an account believed to be controlled by one of our vendors, however it was subsequently discovered that this account was not owned by the vendor. The Company suspects that a threat actor gained access to a valid email account of the vendor and used this account to fraudulently change payment instructions. The Company has notified its insurance carrier and engaged breach counsel as well as a forensics partner to help with the investigation. Pending conclusion of the investigation, approximately $1.0 million has been accrued at December 31, 2025 and March 31, 2026 as the estimated amount of probable loss which is included as part of general and administrative operating expenses.

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

# <u>Note 12 – Income Tax</u> 
The Company's effective tax rate was 0.0% for the three months ended March 31, 2026 and 2025. The reconciliation between the Israel statutory federal income tax rate of 23% and the effective tax rate primarily reflects pre-tax losses incurred in domestic and foreign jurisdictions for which no tax benefit was recognized due to a valuation allowance recorded against the majority of deferred tax assets. The Company maintained a valuation allowance against its deferred tax assets as of both March 31, 2026 and December 31, 2025.

# <u>Note 13 – Segments</u> 
Operating segments are defined as components of an entity for which separate financial information is available and regularly reviewed by the Chief Operating Decision Maker ("CODM") in deciding how to allocate resources and in assessing performance. The Company's CODM is its Chief Executive Officer.

The CODM evaluates the Company's financial information and resources and assesses the performance of these resources on a consolidated basis using adjusted EBITDA.

Adjusted EBITDA is a non-GAAP measure defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization, share-based compensation expense, exchange rate differences, finance expenses (income) for revaluation of assets and liabilities, Desktop Metal litigation related expenses, Desktop Metal and Markforged transaction related expenses, restructuring costs, impact of deconsolidation, impairment losses, litigation settlements and contingencies and step-up amortization from purchase accounting. We believe that Adjusted EBITDA and operating expenses, as described above, should also be useful in evaluating the performance of our business. Like EBITDA, Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting other financial expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from share-based payments, restructuring costs, impairment losses, and step-up amortization from purchase accounting. Adjusted EBITDA and operating expenses are useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company's operating performance without regard to non-cash items, such as expenses related to share-based payments.

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

There is not any revenue, expense, or asset information, that is supplemental to those disclosed in these condensed consolidated financial statements or below, that are regularly provided to the CODM for evaluation of the single operating segment. The adjusted EBITDA reconciliations for the three months ended March 31, 2026 and 2025 are as follow:

---

| | |
|:---|:---|
| **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** |
|  | **Operating Segment** |
| Net loss | $(53456) |
| Depreciation and amortization | 2361 |
| Interest income and expense, net | 211 |
| EBITDA (loss) | (50884) |
| Exchange rate differences | (206) |
| Share-based compensation expense | 917 |
| Impairment losses | 40388 |
| Acquisition inventory step-up amortization | 616 |
| Segment adjusted EBITDA (loss) | $(9169) |
| ***Reconciliation of segment adjusted EBITDA (loss):*** |  |
| Operating segment adjusted EBITDA (loss) | $(9169) |
| Corporate reconciling items: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss<sup>(1)</sup> | (16206) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income and expense, net | (3642) |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance expenses (income) from revaluation of assets and liabilities | 8434 |
| &nbsp;&nbsp;&nbsp;&nbsp;Exchange rate differences | 346 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 2008 |
| &nbsp;&nbsp;&nbsp;&nbsp;Desktop Metal and Markforged transaction related expenses | 556 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs | 3127 |
| &nbsp;&nbsp;&nbsp;&nbsp;Litigation, settlements, and contingencies | 1951 |
| Adjusted EBITDA (loss) | $(12524) |

---

<sup>(1)</sup> Net loss in corporate adjustments relate to those costs incurred at the parent company level, such as financing gains and losses, gains and losses on marketable securities, and corporate overhead costs inclusive of public company costs, legal, corporate headcount, and real estate related costs.

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

---

| | |
|:---|:---|
| **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** |
|  | **Operating Segment** |
| Net loss | $(11000) |
| Income tax (benefit) expense | 23 |
| Depreciation and amortization | 513 |
| EBITDA (loss) | (10464) |
| Exchange rate differences | 239 |
| Share-based compensation expense | 705 |
| Impairment losses | 1229 |
| Segment adjusted EBITDA (loss) | $(8291) |
| ***Reconciliation of segment adjusted EBITDA (loss):*** |  |
| Operating segment adjusted EBITDA (loss) | $(8291) |
| Corporate reconciling items: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss<sup>(1)</sup> | (14548) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income and expense, net | (9309) |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance expenses (income) from revaluation of assets and liabilities | (8726) |
| &nbsp;&nbsp;&nbsp;&nbsp;Exchange rate differences | 1400 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | (1491) |
| &nbsp;&nbsp;&nbsp;&nbsp;Desktop Metal litigation related expenses | 28069 |
| &nbsp;&nbsp;&nbsp;&nbsp;Desktop Metal and Markforged transaction related expenses | 1515 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs | 1180 |
| Adjusted EBITDA (loss) | $(10140) |

---

# <u>Note 14 – Net Profit (Loss) Per Share</u> 
The Company computes basic net profit (loss) per share using net profit (loss) attributable to the Company's common shareholders and the weighted-average number of common shares outstanding during each period. Diluted earnings per share include shares issuable upon exercise of outstanding stock options and stock-based awards where the conversion of such instruments would be dilutive. The Company does this through the treasury stock method. The calculations presented below represent the basic and diluted net profit (loss) per share for all classes of securities.

---

| | | |
|:---|:---|:---|
|  | **Three months ended March 31,** | **Three months ended March 31,** |
|  | **2026** | **2025** |
| **Numerator:** |  |  |
| Net loss | $(69662) | $(25548) |
| Less: Net loss attributable to non-controlling interests |  | (236) |
| Net loss attributable to common shareholders | $(69662) | $(25312) |
| **Denominator:** |  |  |
| Weighted-average shares outstanding - Basic | 207504 | 216462 |
| *Add:* Weighted average unvested options and warrants outstanding |  |  |
| *Add*: Dilutive effect of restricted units issued |  |  |
| Weighted-average shares outstanding - Diluted | 207504 | 216462 |
| **Net loss per common share:** |  |  |
| Basic and Diluted |  |  |
| Net loss attributable to common shareholders | $(0.34) | $(0.12) |

---

For the three months ended March 31, 2026 and 2025, the Company was in a net loss position, thus the effect of potentially dilutive securities was excluded from the denominator for the calculation of diluted net loss per share because the inclusion of such securities would be antidilutive. The following dilutive securities are excluded from the denominator:

------

**NANO DIMENSION LTD.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except share and per share data)**

---

| | | |
|:---|:---|:---|
|  | **For the three months ended March 31,** | **For the three months ended March 31,** |
|  | **2026** | **2025** |
| Unvested or unexercised option awards | 298334 | 2465035 |
| Unvested RSUs | 6031691 | 8883576 |
| Warrants | 29242103 | 33680126 |
| Total | 35572128 | 45028737 |

---

# <u>Note 15 – Subsequent Events</u> 
On April 6, 2026, the Company announced the sale of its additively manufactured electronics (AME) product line and their previously discontinued Fabrica product line to Inspira Technologies OXY B.H.N. Ltd. ("Inspira"). The total consideration payable in connection with the transaction is up to $12.5 million, consisting of a $2.0 million upfront cash payment, and up to $10.5 million of deferred payments tied to the future performance of the product lines over the next twelve months. Inspira assumed operational control of the product lines effective immediately. Completion of the transaction remains subject to the receipt of customary regulatory approvals. The Company has determined that the carrying value of the assets sold approximates the estimated fair value of the consideration. Accordingly, the Company does not expect to recognize a material gain or loss.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.**

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. This discussion and other parts of this Quarterly Report on Form 10-Q contain forward-looking statements based upon current expectations of management that involve risks and uncertainties. Actual results could differ materially from those discussed in or implied by forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K filed with the SEC on March 31, 2026, particularly in the "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors" sections.

**Overview**

We engage in industrial manufacturing solutions of multi-disciplinary technology - combining hardware, software, and materials science. These solutions are used for design-to-manufacturing of electronics and mechanical parts by advanced industrial customers in aerospace, defense, automotive, electronics, medical, research and academia, as well as government organizations.

Since our inception, we have incurred significant operating losses. Our ability to generate revenue sufficient to achieve profitability will depend on the successful further development and commercialization of our products. We generated revenue of $29.7 million and $14.4 million for the three months ended March 31, 2026 and 2025, respectively, and incurred net losses of $69.6 million, inclusive of $40.4 million of goodwill impairment, and $25.5 million, respectively, for those same periods. As of March 31, 2026, we had an accumulated loss of $1,040.6 million and cash, cash equivalents, bank deposits and marketable securities of $439.8 million. We expect to continue to incur operating losses over the next twelve months while we continue to evaluate our business operations for opportunities to improve performance.

**Impact of Macroeconomic Trends** 

Recent negative macroeconomic factors, such as tariffs, inflation, interest rates, geopolitical instability and limited credit availability have and could further cause economic uncertainty and volatility, which could harm our business, result in price pressure or budget constraints.

**Key Factors Affecting Operating Results** 

We believe that our financial performance has been and in the foreseeable future will continue to be primarily driven by the factors discussed below. While each of these factors presents significant opportunities for our business, they also pose important challenges that we must successfully address in order to sustain our growth and improve our results of operations.

**Hardware sales** 

Our financial performance has largely been driven by, and in the future will continue to be impacted by, the rate of sales of our hardware. Management focuses on hardware sales as an indicator of current business success and a leading indicator of likely future recurring revenue from consumables and software and subscription services. We expect our hardware sales to grow in the future as we increase penetration in our existing markets and expand into new markets.

**Go to market** 

We believe that we are in a strong position within the industry with our accessible solutions that offer users design flexibility and industrial strength parts. Accordingly, we continue to invest in marketing, sales, and operations necessary to scale our business and continue to gain market share and open new market opportunities. We have proven an ability to design, manufacture, and distribute products through channels that provide a high value to customers at gross margins higher than many of our competitors. In addition to our go to market strategy, our integrated platform of hardware, software and consumables has been core to our success and we will continue to drive value through research and development as we introduce smarter and more adaptive technology that is expected to improve our integrated platform and, ultimately, the value provided by our 3D printers. We believe these investments are critical to achieve long-term scalability, but expect the near term impacts will be a muting of our short term profitability.

------

**Seasonality** 

Our business is generally not subject to seasonality. However, we have historically experienced higher hardware sales in the third and fourth quarters. We believe this trend is likely driven by available funds in federal capital budgets at the end of the third quarter and commercial budgets at year end which they direct towards the evolution of their manufacturing processes through investments in additive manufacturing.

**Components of Results of Operations** 

***Revenue*** 

The majority of our revenue results from the sale of hardware, including our additive manufacturing products, and related consumables. We deliver products and services primarily through a combination of value-added resellers ("VAR") network, who purchase and resell our products to end users, direct sales, and channel partners. Hardware and consumables revenue is recognized upon transfer of control to the customer and generally takes place at the point of shipment. We also generate a portion of our revenue from services, software, and subscriptions. Revenue related to software and subscriptions is recognized ratably over the term of the subscription. Our VARs may provide installation services, as needed depending on the product.

***Cost of revenue*** 

Our cost of revenue consists of the cost of product, maintenance services, personnel costs, third party logistics, freight, warranty fulfillment costs, and overhead.

Cost of products includes the manufacturing cost of our additive manufacturing products and consumables. We utilize a combination of third-party manufacturers for production of our additive manufacturing hardware and our own manufacturing facilities and personnel. The costs of revenue for internally manufactured products include the cost of raw materials, labor conversion costs, and overhead related to our manufacturing operations, including depreciation and amortization. Overhead costs include shipping, storage, and labor. Cost of services includes personnel-related costs associated with our customer success teams' provision of remote and on-site support services to our customers and the costs of replacement parts, as well as software costs. Our cost of revenue also includes indirect costs of providing our products and services to customers which consist primarily of reserves for excess and obsolete inventory and share-based compensation expenses.

***Gross profit and gross margin*** 

Our gross profit is calculated based on the difference between our revenues and cost of revenue. Gross margin is the percentage obtained by dividing gross profit by our revenue. Our gross profit and gross margin are, or may be, influenced by a number of factors, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Market conditions and competition that may impact our pricing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Product mix changes between our printer product lines and consumables trends;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The impact of global supply chain disruptions on the cost to both procure materials and ship materials and finished goods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Growth in the number of customers utilizing our additive manufacturing products and changes in customer utilization rates, which affects sales of our consumable materials and may result in excess or obsolete inventories;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our cost structure for manufacturing operations, including the extent to which we utilize contract manufacturers compared to in-house manufacturing, the ability to achieve economies of scale in our purchase volumes, and any impacts to changes in our manufacturing on our product warranty obligations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Our ability to directly monetize the capabilities of our software solutions in the future.

We expect our gross margins to fluctuate over time, depending on the factors described above.

------

***Research and development*** 

Our research and development expenses consist of payroll and related expenses, share-based compensation expenses, depreciation, subcontractors expenses, materials for R&D use, rental fees and maintenance, patent registration fees and other related research and development expenses.

***Sales and marketing*** 

Sales and marketing expenses consist of payroll and related expenses, marketing and advertising services, travel expenses, depreciation, share-based compensation expenses, facilities costs, and other demand generation services.

***General and administrative*** 

General and administrative expenses consist of payroll and related expenses for our executive leadership and finance, human resources and IT departments, professional services, share-based compensation expenses, legal fees, transaction costs, depreciation, travel expenses, office expenses, facilities costs as well as other general and administrative expenses.

***Restructuring***

Restructuring costs are costs incurred related to cost savings initiatives and the Strategic Alternative Review announced on September 9, 2025, including losses from the deconsolidation of subsidiaries that do not meet the definition of discontinued operations.

***Desktop Metal litigation***

Desktop Metal litigation expenses include the costs incurred by the Company related to litigation brought against the Company by Desktop Metal prior to the acquisition. On December 16, 2024, Desktop filed a lawsuit against the Company in the Delaware Court of Chancery alleging that we failed to use our reasonable best efforts to obtain regulatory approval in connection with the Merger Agreement entered into on July 2, 2024, or Merger Agreement. We brought counterclaims against Desktop in connection with its obligations under the Merger Agreement, including its obligations to operate its business in the ordinary course and not to experience a bankruptcy. On December 31, 2024, Desktop filed an additional lawsuit in the Delaware Court of Chancery seeking to enjoin the Company and Markforged from consummating the acquisition of Markforged before we consummated the merger with Desktop. In that lawsuit, Desktop alleged that if the acquisition of Markforged were to be consummated before the merger with Desktop, it would violate the terms of the Merger Agreement. The court consolidated the Markforged action with Desktop's initial suit. These claims proceeded through discovery and to trial in the Delaware Court of Chancery, which trial took place on March 11-12, 2025. On March 24, 2025, the Delaware Court of Chancery ruled in Desktop's favor and ordered the Company to proceed to close the Desktop transaction. On April 2, 2025, the parties finalized the transaction and filed a stipulation of dismissal in the Delaware Court of Chancery.

***Impairment losses***

Consists of impairment expenses related to the impairment of goodwill, right-of-use assets, disposal of property, plant, and equipment, and intangible assets.

***(Loss) gain on investment in marketable equity securities***

Consists of the revaluation of our investment in Stratasys, which is measured at fair value.

***Finance income*** 

Finance income includes bank interest earned on deposits, exchange rate differences, revaluation of financial assets and liabilities through profit and loss.

***Finance expense***

Finance expense exchange rate differences, revaluation of financial assets and liabilities through profit and loss, revaluation of government grant liabilities, and interest related to the Continuous Composites settlement that will accrete $1.8 million of interest over the payment term.

------

***Income tax expense***

We have historically recorded an immaterial income tax expense each year since our inception due to ongoing operating losses.

**Fiscal Year 2025 Acquisitions and Subsequent Bankruptcy** 

On April 2, 2025, we acquired Desktop Metal, a provider of industrial-grade 3D printers, materials, and software. The acquisition of Desktop Metal was expected to generate operational synergies, while expanding our customer base and global market presence across key industries. On July 28, 2025, Desktop Metal filed for bankruptcy protection under Chapter 11 of the Bankruptcy Code and all income producing assets were sold in the third quarter of 2025. The purchase price of Desktop Metal was $180.3 million. The acquisition was funded through available cash.

The condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2025 includes impairment of the asset group of $139.4 million and loss from operations for the period of acquisition through the date that the bankruptcy plan was approved of $53.9 million, which are both included within net loss from discontinued operations.

On April 25, 2025, we acquired Markforged, a provider of cloud-based software products (including its software enabled platform, the Digital Forge) and hardware products, including precise and reliable 3D printers, proprietary metal and composite materials to bring industrial production to the point of need on the factory floor. Taking control of Markforged is expected to enable us to access Markforged's additive manufacturing technology, facilitating a broader, more integrated product portfolio. The purchase price of Markforged was $116.2 million. The acquisition was funded through available cash.

**Critical Accounting Policies and Estimates**

A "critical accounting policy" is one which is both important to the portrayal of our financial condition and results of operations and requires management's subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. There have been no material changes to our critical accounting policies since December 31, 2025. For a description of our critical accounting policies that affect our significant judgments and estimates used in the preparation of our condensed consolidated financial statements, refer to Note 2, "Summary of Significant Accounting Policies" included in Part II, Item 8, "Financial Statements and Supplementary Data" to the Company's Annual Report on Form 10-K for the year ended December 31, 2025.

***Recent accounting pronouncements*** 

Refer to Note 2 of our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for the recent accounting pronouncements that we have adopted and have not yet adopted.

------

**Results of Operations**

**Comparison of the three months ended March 31, 2026 and 2025**

***Revenue and Net Loss***

The following table presents consolidated revenue and net loss:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** |  |  |
| *(in thousands, except percentages)* | **2026** | **2025** | **$ change** | **% change** |
| Revenue: |  |  |  |  |
| Product | $22931 | $11679 | $11252 | 96% |
| Service | 6794 | 2722 | 4072 | 150% |
| Total revenue | 29725 | 14401 | 15324 | 106% |
| Cost of revenue: |  |  |  |  |
| Product | 14222 | 7081 | 7141 | 101% |
| Service | 3376 | 1479 | 1897 | 128% |
| Total cost of revenue | 17598 | 8560 | 9038 | 106% |
| Gross profit | 12127 | 5841 | 6286 | 108% |
| Research and development | 8204 | 5944 | 2260 | 38% |
| Sales and marketing | 9692 | 5644 | 4048 | 72% |
| General and administrative | 15209 | 5667 | 9542 | 168% |
| Restructuring | 3127 | 1180 | 1947 | 165% |
| Desktop Metal litigation |  | 28069 | (28069) | (100)% |
| Impairment losses | 40388 | 1229 | 39159 | 3186% |
| Total operating loss | (64493) | (41892) | (22601) | 54% |
| (Loss) gain on investment in marketable equity securities | (8435) | 8726 | (17161) | (197)% |
| Finance income | 3512 | 9320 | (5808) | (62)% |
| Finance expense | (246) | (1679) | 1433 | (85)% |
| Loss before income taxes | (69662) | (25525) | (44137) | 173% |
| Income tax expense |  | (23) | 23 | (100)% |
| Net loss | (69662) | (25548) | (44114) | 173% |

---

Total revenue increased $15.3 million, of which $17.1 million was attributable to the acquisition of Markforged, which comprised $13.1 million of product revenue and $4.0 million of service revenue. The Nano legacy product lines experienced lower sales volume largely attributed to increased tariffs and the impact of divestments.

Cost of revenue increased $9.0 million, of which $9.9 million was attributable to the acquisition of Markforged, $1.6 million cost of service revenue and $8.3 million cost of product revenue, of which $0.6 million is the impact of inventory step-up amortization and intangible asset amortization from purchase accounting. This increase was partially offset by the costs associated with the reduction in revenue due to the lower sales volumes for the Nano legacy businesses.

Research and development expense increased $2.3 million, of which $2.7 million was attributable to the acquisition of Markforged. This increase was partially offset by a decrease in legacy payroll and related expenses, largely associated with lower payroll costs due to lower headcount from organizational synergies.

Sales and marketing expense increased $4.0 million due primarily to the acquisition of Markforged which added $6.8 million, partially offset by a decrease in legacy payroll and related expenses, largely associated with lower payroll costs due to lower headcount from organizational synergies.

------

General and administrative expense increased $9.5 million partially due to the acquisition of Markforged, which added $3.5 million of general and administrative costs. Stock based compensation expense increased $3.6 million due to one-time grants to our directors in the first quarter of 2026 contrasted with the reversal of expense in the first quarter of 2025 due to executive turnover. The remaining change is attributed to an increase in accrual for contingencies and related professional service costs.

Restructuring expense increased $1.9 million due to the ongoing strategic alternative review announced on September 9, 2025. These costs include professional service fees from our banking partners, legal services, and other related costs.

We incurred $28.1 million of litigation expense associated with the 2025 Desktop Metal acquisition litigation during the three months ended March 31, 2025 that did not recur in the three months ended March 31, 2026.

Impairment losses increased $39.2 million in 2026 due to impairment of the Markforged FFF product line goodwill balance of $40.4 million. The impairment loss in the first quarter of 2025 consisted of property, plant, and equipment related to the discontinuation of product lines, primarily Admatec.

***(Loss) Gain on Investment in Marketable Equity Securities***

Loss on investment in marketable equity securities for the three months ended March 31, 2026 was a loss of $8.4 million compared to a gain of $8.7 million for the three months ended March 31, 2025. These changes are consistent with the change in share price of Stratasys Ltd. (SYSS) over both periods.

***Finance Income and Expense***

We recognized net financial income of $3.2 million for the three months ended March 31, 2026, compared to $7.6 million for the three months ended March 31, 2025, a decrease of $4.4 million. The decrease is primarily attributed to a decrease of in bank interest due to lower cash balances and interest rates.

------

**Liquidity and Capital Resources**

***Overview***

Since our inception through March 31, 2026, we have funded our operations principally with $1.6 billion from issuance of Ordinary Shares, warrants and convertible notes. As of March 31, 2026, we held $355.3 million in cash and cash equivalents along with an additional $8.8 million in short-term unrestricted bank deposits.

Our material cash requirements from known contractual and other obligations relate to minimum operating lease obligations. We are also subject to ongoing payment obligations. For example, pursuant to the Settlement Agreement, we will be required to make installment payments thereafter of $2.0 million and $4.0 million in the fourth quarters of fiscal years 2026 and 2027, respectively, which payments represent substantial ongoing payment obligations.

The table below presents our cash flows:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| *(in thousands)* | **2026** | **2025** |
| Cash flows used in operating activities | $(7079) | $(7479) |
| Cash flow from investing activities | 157484 | 177100 |
| Cash flow used in financing activities | (41) | (35) |
| Effect of exchange rate fluctuations on cash | 357 | 204 |
| Net increase in cash, cash equivalents and restricted cash | $150721 | $169790 |

---

***Operating Activities***

Net cash used in operating activities of $7.1 million during the three months ended March 31, 2026 was primarily used for payment of payroll and related expenses, professional services, and costs related to restructuring efforts, offset by interest received from banks.

Net cash used in operating activities of $7.5 million during the three months ended March 31, 2025 was primarily used for payment of payroll and related expenses, rental fees and maintenance, travel and other miscellaneous expenses, offset by interest received from banks and the accrual of litigation and transaction related costs for the Desktop Metal and Markforged acquisitions.

***Investing Activities***

Net cash from investing activities of $157.5 million during the three months ended March 31, 2026 was primarily due to the maturity of long term deposits (investments) being reinvested in short term deposits to maximize available liquidity and are classified as cash and cash equivalents on the condensed consolidated balance sheets.

Net cash from investing activities of $177.1 million during the three months ended March 31, 2025 was the offset of the change in our cash in bank deposits used to finance the purchase of Desktop Metal in April 2025.

***Financing Activities***

Net cash used in financing activities was immaterial for the three months ended March 31, 2026 and 2025.

***Share Repurchase***

In January 2025, our board of directors authorized a repurchase plan, or the $150 million Repurchase Plan, allowing us to invest up to $150 million to repurchase ADSs from time to time, in open market transactions, and/or in privately negotiated transactions or in any other legally permissible ways, depending on market conditions, share price, trading volume and other factors. During 2025, 14.4 million shares were repurchased under the $150 million Repurchase Plan. As of the date hereof, no shares have been repurchased during 2026.

------

***Current Outlook***

To date, we have not achieved profitability and have sustained net losses in every fiscal year since our inception, and we have financed our operations primarily through proceeds from issuance of our Ordinary Shares, warrants and convertible notes. Our primary requirements for liquidity and capital resources are to finance working capital, capital expenditures and general corporate purposes.

We believe we will continue to incur operating losses and negative cash flows in the near-term as we continue to invest in our business, in particular across our research and development efforts and sales and marketing programs. Nevertheless, we believe that our current resources will be sufficient to meet our business needs for at least the next 12 months and into 2027.

In addition, our operating plans may change as a result of many factors that may currently be unknown to us, and we may need to seek additional funds sooner than planned. Our future capital requirements will depend on many factors, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•our continued efforts to explore strategic alternatives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the progress and costs of our research and development activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the progress of commercial sales of our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the costs of manufacturing our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the costs of filing, prosecuting, enforcing and defending patent claims, intellectual property rights and other legal claims;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities internally; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the magnitude of our general and administrative expenses.

**Non-GAAP Metrics**

EBITDA is a non-GAAP measure and is defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization. We believe that EBITDA should be useful in evaluating the performance of our business and operations. EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting interest expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively) and EBITDA is useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company's operating performance without regard to the items mentioned above.

Adjusted EBITDA and operating expenses are non-GAAP measures and are defined as earnings before interest income and expense, income tax (benefit) expense, depreciation and amortization, share-based compensation expense, exchange rate differences, finance expenses (income) for revaluation of assets and liabilities, Desktop Metal litigation related expenses, Desktop Metal and Markforged transaction related expenses, restructuring costs, impact of deconsolidation, impairment losses, litigation settlements and step-up amortization from purchase accounting. We believe that Adjusted EBITDA and operating expenses, as described above, should also be useful in evaluating the performance of our business. Like EBITDA, Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in capital structures (affecting other financial expenses (income), net), and the age and depreciation charges and amortization of fixed and intangible assets, respectively (affecting relative depreciation and amortization expense, respectively), as well as from share-based payments, restructuring costs, impairment losses, and step-up amortization from purchase accounting. Adjusted EBITDA and operating expenses are useful to an investor in evaluating our operating performance because it is widely used by investors, securities analysts and other interested parties to measure a company's operating performance without regard to non-cash items, such as expenses related to share-based payments.

EBITDA, Adjusted EBITDA, and Adjusted gross profit can be useful in evaluating our performance by eliminating the effect of financing and non-cash expenses such as share-based payments, however, we may incur such expenses in the future, which could

------

impact future results. In addition, other companies, including companies in our industry, may calculate non-GAAP metrics differently or not at all, which may reduce the usefulness of this measure as a tool for comparison.

The following is a reconciliation of net loss to EBITDA and Adjusted EBITDA:

---

| | | |
|:---|:---|:---|
|  | **For the** | **For the** |
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31,** | **March 31,** |
| *(In thousands)* | **2026** | **2025** |
| Net loss | $(69662) | $(25548) |
| Income tax expense |  | 23 |
| Depreciation and amortization | 2432 | 574 |
| Interest expense | 221 |  |
| Interest income | (3652) | (9309) |
| EBITDA (loss) | (70661) | (34260) |
| Finance expenses (income) from revaluation of assets and liabilities | 8434 | (8726) |
| Exchange rate differences | 140 | 1639 |
| Share-based compensation expense | 2925 | (786) |
| Desktop Metal litigation related expenses |  | 28069 |
| Desktop Metal and Markforged transaction related expenses | 556 | 1515 |
| Restructuring costs | 3127 | 1180 |
| Impairment losses | 40388 | 1229 |
| Acquisition inventory step-up amortization | 616 |  |
| Litigation, settlements, and contingencies | 1951 |  |
| Adjusted EBITDA (loss) | $(12524) | $(10140) |

---

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.**

In the ordinary course of our operations, we are exposed to certain market risks, primarily changes in foreign currency exchange rates and interest rates.

**Quantitative and Qualitative Disclosure About Market Risk**

There have been no material changes to our market risk exposures since December 31, 2025. For information regarding our exposure to certain market risks, see "Quantitative and Qualitative Disclosures About Market Risk", included in Part II, Item 7A, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the Securities and Exchange Commission on March 31, 2026.

**ITEM 4. CONTROLS AND PROCEDURES.** 

**Disclosure Controls and Procedures**

Management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended ("the Exchange Act")), as of the end of the period covered by this report. Based on such evaluation, our CEO and CFO concluded that our disclosure controls and procedures were not effective as of the end of such period because of the material weakness in internal control over financial reporting described below.

------

**Material Weaknesses in Internal Control Over Financial Reporting**

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

In April 2025, we completed our acquisitions of Desktop Metal, Inc. ("Desktop Metal") and Markforged Holding Corporation ("Markforged") (collectively the "Acquisitions"). In July 2025, we disposed of Desktop Metal. We are in the process of evaluating the existing controls and procedures of Markforged and integrating Markforged into our internal control over financial reporting. In accordance with SEC Staff guidance permitting a company to exclude an acquired business from management's assessment of the effectiveness of internal control over financial reporting for one year following the date on which the acquisition is completed, we have excluded Markforged from our evaluation of the internal control over financial reporting. The excluded business, excluding goodwill and intangible assets of $40.3 million and $19.4 million which are included in the scope of the assessment, constituted approximately 15% of total assets and 53% of revenues as of and for the year ended December 31, 2025.

Based on this assessment, our CEO and CFO concluded that the Company did not maintain sufficient resources with an appropriate level of accounting knowledge, training and experience in the accounting for business combinations and discontinued operations to fulfill our responsibilities with respect to internal control over financial reporting. As a result, we did not design and operate effective process level control activities related to the accounting and disclosure for the Acquisitions, including valuation of certain acquired intangible assets, and discontinued operations of Desktop Metal.

**Remediation Plan for Material Weakness**

Management, with the oversight of the Audit Committee, is currently taking actions to remediate the material weakness and is designing and will implement additional processes and controls to address the underlying causes associated with the material weakness described above. We have begun the process to remediate the material weakness and will continue our efforts through fiscal 2026. The remediation efforts include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Enhancing our risk assessment process to identify and assess risks of material misstatement and to ensure controls are designed and implemented to respond to those risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Engaging additional third-party personnel and/or hiring additional competent and qualified technical accounting and financial reporting personnel with appropriate knowledge and experience of U.S. GAAP and SEC financial reporting requirements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Training of new personnel and existing personnel in new roles on proper execution of designed control procedures.

The material weakness identified above will not be considered fully remediated until these additional controls and procedures have operated effectively for a sufficient period of time and management has concluded, through testing, that these controls are effective. Our management will monitor the effectiveness of our remediation plans and will make changes management determines to be appropriate.

**Changes in Internal Control over Financial Reporting**

Except for the remediation changes that are being implemented, as described above, no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

**ITEM 1. Legal Proceedings**

From time to time, we are subject to certain legal proceedings, claims and disputes that arise in the ordinary course of our business. Although we cannot predict the outcomes of these legal proceedings, these actions, in the aggregate, could have a material adverse impact on our financial position, results of operations or liquidity. A description of our legal proceedings is included in "Item 1. Financial Statements, Note 11. Commitments and Contingencies," and is incorporated herein by reference.

------

**ITEM 1A. RISK FACTORS**

There have been no material changes to the Company's risk factors since our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 31, 2026.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**

None.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES** 

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5. OTHER INFORMATION**

(c)*Securities Trading Plans of Directors and Executive Officers*

During the three months ended March 31, 2026, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

------

**ITEM 6. Exhibits**

The exhibits filed with or incorporated into this Quarterly Report are listed below.

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| 4.1 | [<u>Rights Agreement, dated February 2, 2026, by and between Nano Dimension Ltd. and the Bank of New York Mellon, filed as Exhibit 4.1 to Report on Form 6-K (File No. 001-37600), filed on February 3, 2026, and incorporated herein by reference.</u>](https://www.sec.gov/Archives/edgar/data/1643303/000110465926009462/tm264887d2_ex4-1.htm) |
| 31.1\* | [<u>Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, filed herewith.</u>](nndm-ex31_1.htm) |
| 31.2\* | [<u>Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, filed herewith.</u>](nndm-ex31_2.htm) |
| 32.1\*+ | [<u>Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350, furnished herewith.</u>](nndm-ex32_1.htm) |
| 32.2\*+ | [<u>Certification of the Chief Financial Officer pursuant to 18 U.S.C. 1350, furnished herewith.</u>](nndm-ex32_2.htm) |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbases document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Exhibits filed herein. All exhibits not so designated are incorporated by reference to a prior filing, as indicated.

+ This certification will not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp;Nano Dimension Ltd. | &nbsp;&nbsp;&nbsp;&nbsp;Nano Dimension Ltd. |
| &nbsp;&nbsp;&nbsp;&nbsp;Date: May 7, 2026 | &nbsp;&nbsp;&nbsp;&nbsp;By: | /s/ David Stehlin<br>|
|  |  | &nbsp;&nbsp;David Stehlin |
|  |  | &nbsp;&nbsp;Chief Executive Officer<br>(Principal Executive Officer) |
| &nbsp;&nbsp;&nbsp;&nbsp;Date: May 7, 2026 | &nbsp;&nbsp;&nbsp;&nbsp;By: | /s/ John Brenton |
|  |  | &nbsp;&nbsp;John Brenton |
|  |  | &nbsp;&nbsp;Chief Financial Officer<br>(Principal Financial and Accounting Officer) |

---

------

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION**

I, David Stehlin, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 of Nano Dimension Ltd.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 7, 2026 | &nbsp;&nbsp;&nbsp;&nbsp;By: | /s/ David Stehlin |
|  |  |  | David Stehlin |
|  |  |  | Chief Executive Officer |
|  |  |  | (Principal Executive Officer) |

---

------

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION**

I, John Brenton, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 of Nano Dimension Ltd.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 7, 2026 | By: | /s/ John Brenton |
|  |  |  | John Brenton |
|  |  |  | Chief Financial Officer |
|  |  |  | (Principal Financial and Accounting Officer) |

---

------

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Nano Dimension Ltd. (the "Company") for the quarter ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David Stehlin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 7, 2026 | By: | /s/ David Stehlin |
|  |  | David Stehlin |
|  |  | Chief Executive Officer<br>(Principal Executive Officer) |

---

------

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of Nano Dimension Ltd. (the "Company") for the quarter ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John Brenton, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: May 7, 2026 | By: | /s/ John Brenton |
|  |  | John Brenton |
|  |  | Chief Financial Officer<br>(Principal Financial and Accounting Officer) |

---

------